These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 31054852)

  • 21. The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.
    Creasy JM; Sadot E; Koerkamp BG; Chou JF; Gonen M; Kemeny NE; Saltz LB; Balachandran VP; Peter Kingham T; DeMatteo RP; Allen PJ; Jarnagin WR; D'Angelica MI
    Ann Surg Oncol; 2018 Feb; 25(2):431-438. PubMed ID: 29181680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the site of primary colorectal cancer influence the outcome after resection of isolated liver metastases?
    Makowiec F; Menzel M; Bronsert P; Holzner PA; Klock A; Lang SA; Fichtner-Feigl S; Neeff HP
    Dig Liver Dis; 2018 Oct; 50(10):1088-1092. PubMed ID: 30055964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer.
    Suthananthan AE; Bhandari M; Platell C
    ANZ J Surg; 2018 May; 88(5):445-449. PubMed ID: 28512795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microwave ablation with or without resection for colorectal liver metastases.
    Stättner S; Jones RP; Yip VS; Buchanan K; Poston GJ; Malik HZ; Fenwick SW
    Eur J Surg Oncol; 2013 Aug; 39(8):844-9. PubMed ID: 23769976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases.
    Daza JF; Solis NM; Parpia S; Gallinger S; Moulton CA; Belley-Cote EP; Levine MN; Serrano PE
    Eur J Surg Oncol; 2019 Aug; 45(8):1341-1348. PubMed ID: 30928334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
    Kawaguchi Y; Kopetz S; Tran Cao HS; Panettieri E; De Bellis M; Nishioka Y; Hwang H; Wang X; Tzeng CD; Chun YS; Aloia TA; Hasegawa K; Guglielmi A; Giuliante F; Vauthey JN
    Br J Surg; 2021 Aug; 108(8):968-975. PubMed ID: 33829254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases.
    Dupré A; Malik HZ; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ
    Eur J Surg Oncol; 2018 Jan; 44(1):80-86. PubMed ID: 29183640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of preoperative prognostic factors for long-term survival after hepatic resection of liver metastasis of colorectal carcinoma.
    Sasaki A; Iwashita Y; Shibata K; Matsumoto T; Ohta M; Kitano S
    J Gastrointest Surg; 2005 Mar; 9(3):374-80. PubMed ID: 15749600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which is more effective in the treatment of hepatic metastases from colorectal cancer: SBRT or RFA?
    Cihan YB
    Colorectal Dis; 2018 Sep; 20(9):822-823. PubMed ID: 29924499
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of early recurrences following liver resection by ALPPS and two stage hepatectomy in patients with colorectal liver-metastases and small future liver remnants; a translational substudy of the LIGRO-RCT.
    Røsok BI; Høst-Brunsell T; Brudvik KW; Carling U; Dorenberg E; Björnsson B; Lothe RA; Bjørnbeth BA; Sandström P
    HPB (Oxford); 2019 Aug; 21(8):1017-1023. PubMed ID: 30765198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-varying prognostic effects of primary tumor sidedness and grade after curative liver resection for colorectal liver metastases.
    Syn NL; Chua DW; Raphael Chen L; Tan YC; Goh BKP; Chung Cheow P; Jeyaraj PR; Koh Y; Chung A; Yee Lee S; Lucien Ooi L; Tai BC; Yip Chan C; Teo JY
    Surg Oncol; 2021 Sep; 38():101586. PubMed ID: 33933898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?
    Sadot E; Groot Koerkamp B; Leal JN; Shia J; Gonen M; Allen PJ; DeMatteo RP; Kingham TP; Kemeny N; Blumgart LH; Jarnagin WR; DʼAngelica MI
    Ann Surg; 2015 Sep; 262(3):476-85; discussion 483-5. PubMed ID: 26258316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver metastases from colorectal cancer: present surgical approach.
    Cavallari A; Vivarelli M; Bellusci R; Montalti R; De Ruvo N; Cucchetti A; De Vivo A; De Raffele E; Salone M; La Barba G
    Hepatogastroenterology; 2003; 50(54):2067-71. PubMed ID: 14696466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver metastases from gastric cancer represent systemic disease in comparison with those from colorectal cancer.
    Oguro S; Imamura H; Yoshimoto J; Ishizaki Y; Kawasaki S
    J Hepatobiliary Pancreat Sci; 2016 Jun; 23(6):324-32. PubMed ID: 26946472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis.
    Araujo RL; Gönen M; Herman P
    Ann Surg Oncol; 2015 Sep; 22(9):3070-8. PubMed ID: 25586244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis.
    Tanaka K; Shimada H; Miura M; Fujii Y; Yamaguchi S; Endo I; Sekido H; Togo S; Ike H
    World J Surg; 2004 Mar; 28(3):263-70. PubMed ID: 14961200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.